Clinical Trial Update: Iberdomide vs. Iberdomide Plus Isatuximab Maintenance Therapy Post ASCT in Newly Diagnosed Multiple Myeloma [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing iberdomide alone versus iberdomide plus isatuximab as maintenance therapy after autologous stem cell transplant in newly diag…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Isatuximab (isatuximab)
• iberdomide (iberdomide)

Snippet

Sponsor: University of Heidelberg Medical Center | Conditions: Multiple Myeloma | Phase 3 | Status: RECRUITING